Benzinga's Top Downgrades
Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.
Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.
RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.
William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.
Latest Ratings for FINL
|Mar 2015||Monness Crespi Hardt||Upgrades||Neutral||Buy|
|Mar 2015||B Riley||Downgrades||Buy||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.